No Data
WXXWY WUXI BIOLGCS ADR
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About WUXI BIOLGCS ADR Company
Wuxi Biologics (Cayman), Inc. is an investment holding company, which engages in the discovery, development and manufacture of biologics services. Its services include testing; clinical drug substance cGMP manufacture; commercial drug substance cGMP manufacture; drug product cGMP fill and finish; antibody drug conjugates; regulatory affairs; and technologies and platforms. The company was founded on May 24, 2010 and is headquartered in Wuxi, China.
Revenue Breakdown
News
Nanbei Water | Nanshui's net sales of A-shares exceeded 7.5 billion dollars throughout the day, sold Wuliangye and Maotai, and Beishui rushed to raise the Prosperity Fund
Track the latest developments in north-south funding
Nomura Adjusts Wuxi Biologics' Price Target to HK$58.44 From HK$82.69, Keeps at Buy
06:14 AM EST, 12/05/2023 (MT Newswires) -- Nomura Adjusts Wuxi Biologics' Price Target to HK$58.44 From HK$82.69, Keeps at Buy Price (HKD): $30.35, Change: $-2.80, Percent Change: -8.45%
The CXO leader continues to collapse! Yaoming Biotech got on the “jumping plane” and plummeted by more than 30% in two days. What do the institutions think?
The decline is unstoppable.
Comments
HSI Opens 39 pts Lower as WUXI Series Continue to be Weak
Chinese pharma $WUXI BIO(02269.HK$ sagged 5% to $31.5 after resumption of trading in the morning session. $WUXI APPTEC(02359.HK$ lost 3.4%.
For financials, $HSBC HOLDINGS(00005.HK$ climbed 0.2% to $59.8, whi...
The trading of Wuxi Biologics was suspended in Hong Kong before a 23.79% slide this morning.
$WUXI BIO(02269.HK$$WUXI APPTEC(02359.HK$

HopelessChi : It’s financial market also another problem for them
102884128 : wuxi series sell down, is it over react?
Mao MM : How to tell. Trading blind.